Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases.

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

www.aldeyra.com →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Here's Why Jacobs Solutions (J) is a Strong Growth Stock

Why MasterCard (MA) is a Top Growth Stock for the Long-Term

Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term

MasTec (MTZ) is a Top-Ranked Growth Stock: Should You Buy?

Here's Why Goldman Sachs (GS) is a Strong Growth Stock

Why PBF Energy (PBF) is a Top Growth Stock for the Long-Term

Here's Why Palomar (PLMR) is a Strong Growth Stock

Transocean (RIG) is a Top-Ranked Growth Stock: Should You Buy?

Here's Why Valero Energy (VLO) is a Strong Growth Stock

Why CrowdStrike Holdings (CRWD) is a Top Growth Stock for the Long-Term

Why Myriad Genetics (MYGN) is a Top Growth Stock for the Long-Term

Why Micron's stock is sliding despite Nvidia-like earnings performance

Intuitive Machines under pressure after fourth quarter earnings miss

Five Below tops estimates with double-digit comps, raises FY26 outlook

FIBRA Prologis Announces an Ordinary Certificate Holders Meeting

Buy 3 Stocks That Announced Dividend Hikes Amid Geopolitical Tensions

Bank of America's Digitization Initiatives Unlocking Revenue Growth

Is GIS' Portfolio Reshaping Strategy Key to Long-Term Growth?

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Is Adecoagro (AGRO) Outperforming Other Consumer Staples Stocks This Year?

About